In March with the assistance of Japanese experts and efforts of the centre's staff, the measles-rubella vaccine was clinically tested and proven safe and effective. The Science Technology and Training Administration has verified that the measles-rubella vaccine produced by the centre has met the requirements in terms of safety and immunity. The centre will accelerate the circulation process to provide this vaccine to the national expanded immunisation programme targeting Vietnamese children by 2017. Vietnam is among 25 nations that can produce vaccines, and four in Asia that can produce the measles-rubella vaccine, following Japan, India and China.
